查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592920

注射筆市場：按類型、應用、最終用戶、適應症分類 - 2025-2030 年全球預測

Injection Pen Market by Type (Disposable, Reusable Pens), Application (Fertility, Growth Hormone Therapy, Insulin Delivery), End User, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年注射筆市場價值為366.7億美元，預計到2024年將達到391.9億美元，複合年成長率為7.79%，到2030年將達到620.2億美元。

注射筆市場範圍被定義為用於自行注射胰島素、生長激素和生物製藥等藥物的醫療設備，為傳統注射器提供了易於使用的替代品。該設備越來越受到關注，因為它需要解決糖尿病等慢性疾病，並透過提高準確性和便利性來促進治療依從性。注射筆應用跨越多個治療領域，主要集中在內分泌學、腫瘤學和自體免疫疾病，最終用途包括醫院、診所和居家照護場所，提高患者的獨立性和依從性。

主要市場統計
基準年[2023] 366.7億美元
預測年份 [2024] 391.9億美元
預測年份 [2030] 620.2億美元
複合年成長率（%） 7.79%

根據市場洞察，注射筆市場的推動因素包括慢性病盛行率上升、對微創給藥設備的需求增加以及智慧筆技術進步帶來的劑量準確性和病患監測的提高。對生物相似藥的需求迅速增加以及製藥公司和設備製造商之間不斷擴大的合作夥伴關係也帶來了商機。為了利用這些機會，公司可以專注於開發具有增強連接性和易於使用設計的筆，以滿足人口老化和新興市場監管核准的需求。

挑戰包括先進注射筆的高價格、新興市場的知名度低以及設備故障的潛在問題，這些可能會阻礙市場的成長。為了保持競爭力，公司面臨克服監管障礙和確保設備生產的永續性的挑戰。創新機會在於增強筆的數位介面，以便更好地與醫療保健系統整合，開發用於永續製造的環保材料，以及結合人工智慧進行個性化藥物輸送。市場的競爭和不斷發展的本質強調以患者為中心的解決方案和法規遵從性，以確保市場領先地位。促進與高科技公司的智慧筆創新合作，並透過強大的分銷網路加強市場滲透，可以成為業務成長的策略路線。

市場動態：揭示快速發展的注射筆市場的關鍵市場洞察

供需的動態交互作用正在改變注射筆市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病盛行率上升，核准數量不斷增加
    • 新興經濟體的有利報銷和政府支持
    • 糖尿病患者擴大使用筆進行胰島素注射
  • 市場限制因素
    • 與注射筆相關的高成本
  • 市場機會
    • 開發輸送裝置技術以滿足對注射筆日益成長的需求
    • 加大研發投入
  • 市場挑戰
    • 偏好其他治療方法

波特五力：駕馭注射筆市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解注射筆市場的外部影響

外部宏觀環境因素對注射筆市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解注射筆市場的競爭狀況

對注射筆市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣注射筆市場廠商績效評估

FPNV定位矩陣是評估注射筆市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定注射筆市場成功之路的策略分析與建議

對於旨在加強其在全球市場的影響力的公司來說，注射筆市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率不斷上升，監管部門核准數量不斷增加
      • 已開發國家的優勢報銷與政府支持
      • 用於糖尿病患者注射胰島素的筆式應用程式正在興起
    • 抑制因素
      • 與注射筆相關的高成本
    • 機會
      • 由於需求增加而開發輸送裝置技術
      • 加大研發投入
    • 任務
      • 更喜歡其他治療方法
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章注射筆市場：依類型

  • 一次性的
  • 可重複使用的筆

第7章注射筆市場：依應用分類

  • 生育力
  • 生長激素荷爾蒙療法
  • 胰島素給藥
  • 骨質疏鬆症

第8章注射筆市場：依最終用戶分類

  • 居家護理
  • 醫院/診所

第9章注射筆市場表現

  • 過敏反應
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 多發性硬化症
  • 類風濕性關節炎

第10章 南北美洲注射筆市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太注射筆市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲筆觸筆市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Aptar Digital Health 與 SHL Medical 合作，透過改善連接性和患者體驗來推動自行注射治療
    • Eisai和 Nippon Medac 在日本推出 Metject 皮下注射筆，為類風濕性關節炎患者增加便利性和安全性
    • 賽諾菲印度公司推出了 Soliqua，這是一種糖尿病治療藥物，可改善肥胖成年人的血糖控制並降低低血糖的風險。
  • 戰略分析和建議

公司名單

  • Amgen Inc.
  • Antares Pharma, Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biocorp Production by Novo Nordisk
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Inolife Sciences Inc.
  • Insulet Corporation
  • Medtronic plc
  • Mylan NV
  • Nemera Development SA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • SHL Medical AG
  • Taiyo Pharma Co., Ltd.
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Wockhardt Limited
  • Ypsomed AG
Product Code: MRR-43127F727987

The Injection Pen Market was valued at USD 36.67 billion in 2023, expected to reach USD 39.19 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 62.02 billion by 2030.

The scope of the injection pen market encompasses its definition as a medical device used for the self-administration of medication, such as insulin, growth hormones, and biologics, offering user-friendly alternatives to traditional syringes. This device is gaining traction due to its necessity in addressing chronic diseases like diabetes, facilitating treatment adherence through improved accuracy and convenience. The application of injection pens spans multiple therapeutic areas, primarily focusing on endocrinology, oncology, and autoimmune diseases, while the end-use scope includes hospitals, clinics, and home care settings, enhancing patient independence and compliance.

KEY MARKET STATISTICS
Base Year [2023] USD 36.67 billion
Estimated Year [2024] USD 39.19 billion
Forecast Year [2030] USD 62.02 billion
CAGR (%) 7.79%

Market insights indicate that the injection pen market is experiencing growth driven by factors such as the rising prevalence of chronic diseases, increasing demand for minimally invasive drug delivery devices, and technological advances in smart pen technology, improving dosage precision and patient monitoring. Opportunities arise from the surge in demand for biosimilars and the expansion of partnerships between pharmaceutical companies and device manufacturers. To capitalize on these opportunities, companies could focus on developing pens with enhanced connectivity features and user-friendly designs, catering to an aging population's needs and regulatory approvals in emerging markets.

Challenges include the high cost of advanced injection pens, limited awareness in developing regions, and potential issues related to device malfunctions, which could hinder market growth. Companies face the task of overcoming regulatory hurdles and ensuring sustainability in device production to maintain competitiveness. Innovation opportunities lie in enhancing the pen's digital interface for better integration with healthcare systems, developing eco-friendly materials for sustainable manufacturing, and incorporating AI for personalized drug delivery. The market's nature is highly competitive and evolving, with an emphasis on patient-centric solutions and regulatory compliance to secure market leadership. Fostering collaborations with tech firms for smart pen innovations and enhancing market penetration through robust distribution networks could serve as strategic routes for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injection Pen Market

The Injection Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases and growing number of regulatory approvals
    • Favorable reimbursement in developed economies and government support
    • Growing application pens by people with diabetes to administer insulin
  • Market Restraints
    • High cost associated with injection pens
  • Market Opportunities
    • Development of delivery device technology owing to rising injection pen demand
    • Growing investments toward research and development
  • Market Challenges
    • Preference towards other modes of treatment

Porter's Five Forces: A Strategic Tool for Navigating the Injection Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injection Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injection Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injection Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injection Pen Market

A detailed market share analysis in the Injection Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injection Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injection Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injection Pen Market

A strategic analysis of the Injection Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injection Pen Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Antares Pharma, Inc., AstraZeneca plc, Bayer AG, Biocorp Production by Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Inolife Sciences Inc., Insulet Corporation, Medtronic plc, Mylan N.V., Nemera Development S.A., Novartis AG, Novo Nordisk A/S, Owen Mumford Ltd., Pfizer Inc., Sanofi S.A., SHL Medical AG, Taiyo Pharma Co., Ltd., Terumo Corporation, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services, Inc., Wockhardt Limited, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Injection Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Disposable and Reusable Pens.
  • Based on Application, market is studied across Fertility, Growth Hormone Therapy, Insulin Delivery, and Osteoporosis.
  • Based on End User, market is studied across Homecare and Hospitals & Clinics.
  • Based on Indication, market is studied across Anaphylaxis, Cancer, Cardiovascular Diseases, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases and growing number of regulatory approvals
      • 5.1.1.2. Favorable reimbursement in developed economies and government support
      • 5.1.1.3. Growing application pens by people with diabetes to administer insulin
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with injection pens
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of delivery device technology owing to rising injection pen demand
      • 5.1.3.2. Growing investments toward research and development
    • 5.1.4. Challenges
      • 5.1.4.1. Preference towards other modes of treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Injection Pen Market, by Type

  • 6.1. Introduction
  • 6.2. Disposable
  • 6.3. Reusable Pens

7. Injection Pen Market, by Application

  • 7.1. Introduction
  • 7.2. Fertility
  • 7.3. Growth Hormone Therapy
  • 7.4. Insulin Delivery
  • 7.5. Osteoporosis

8. Injection Pen Market, by End User

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals & Clinics

9. Injection Pen Market, by Indication

  • 9.1. Introduction
  • 9.2. Anaphylaxis
  • 9.3. Cancer
  • 9.4. Cardiovascular Diseases
  • 9.5. Diabetes
  • 9.6. Multiple Sclerosis
  • 9.7. Rheumatoid Arthritis

10. Americas Injection Pen Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Injection Pen Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Injection Pen Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aptar Digital Health and SHL Medical partnership to enhance self-injectable therapies through enhanced connectivity and patient experience
    • 13.3.2. Eisai and nippon medac launch Metoject Subcutaneous Injection Pen in Japan to enhance convenience and safety for rheumatoid arthritis patients
    • 13.3.3. Sanofi India launched Soliqua, a daily diabetes injection pen targeting obese adults to improve glycaemic control and reduce hypoglycemia risk
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen Inc.
  • 2. Antares Pharma, Inc.
  • 3. AstraZeneca plc
  • 4. Bayer AG
  • 5. Biocorp Production by Novo Nordisk
  • 6. Eli Lilly and Company
  • 7. F. Hoffmann-La Roche AG
  • 8. Gerresheimer AG
  • 9. Inolife Sciences Inc.
  • 10. Insulet Corporation
  • 11. Medtronic plc
  • 12. Mylan N.V.
  • 13. Nemera Development S.A.
  • 14. Novartis AG
  • 15. Novo Nordisk A/S
  • 16. Owen Mumford Ltd.
  • 17. Pfizer Inc.
  • 18. Sanofi S.A.
  • 19. SHL Medical AG
  • 20. Taiyo Pharma Co., Ltd.
  • 21. Terumo Corporation
  • 22. Teva Pharmaceuticals Industries Ltd.
  • 23. West Pharmaceutical Services, Inc.
  • 24. Wockhardt Limited
  • 25. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. INJECTION PEN MARKET RESEARCH PROCESS
  • FIGURE 2. INJECTION PEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INJECTION PEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INJECTION PEN MARKET DYNAMICS
  • TABLE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INJECTION PEN MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INJECTION PEN MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INJECTION PEN MARKET SIZE, BY FERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INJECTION PEN MARKET SIZE, BY GROWTH HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INJECTION PEN MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INJECTION PEN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INJECTION PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INJECTION PEN MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INJECTION PEN MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INJECTION PEN MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INJECTION PEN MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INJECTION PEN MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INJECTION PEN MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023